Pecans and Its Polyphenols Prevent Obesity, Hepatic Steatosis and Diabetes by Reducing Dysbiosis, Inflammation, and Increasing Energy Expenditure in Mice Fed a High-Fat Diet

Nutrients. 2023 May 31;15(11):2591. doi: 10.3390/nu15112591.

Abstract

Pecans (Carya illinoinensis) are considered a functional food due to the high content of polyunsaturated fatty acids, dietary fiber and polyphenols. To determine the effect of whole pecans (WP) or a pecan polyphenol (PP) extract on the development of metabolic abnormalities in mice fed a high-fat (HF) diet, we fed C57BL/6 mice with a Control diet (7% fat), HF diet (23% fat), HF containing 30% WP or an HF diet supplemented with 3.6 or 6 mg/g of PP for 18 weeks. Supplementation of an HF diet with WP or PP reduced fat mass, serum cholesterol, insulin and HOMA-IR by 44, 40, 74 and 91%, respectively, compared to the HF diet. They also enhanced glucose tolerance by 37%, prevented pancreatic islet hypertrophy, and increased oxygen consumption by 27% compared to the HF diet. These beneficial effects were associated with increased thermogenic activity in brown adipose tissue, mitochondrial activity and AMPK activation in skeletal muscle, reduced hypertrophy and macrophage infiltration of subcutaneous and visceral adipocytes, reduced hepatic lipid content and enhanced metabolic signaling. Moreover, the microbial diversity of mice fed WP or PP was higher than those fed HF, and associated with lower circulating lipopolysaccharides (~83-95%). Additionally, a 4-week intervention study with the HF 6PP diet reduced the metabolic abnormalities of obese mice. The present study demonstrates that WP or a PP extract prevented obesity, liver steatosis and diabetes by reducing dysbiosis, inflammation, and increasing mitochondrial content and energy expenditure. Pecan polyphenols were mainly condensed tannin and ellagic acid derivatives including ellagitannins as determined by LC-MS. Herein we also propose a model for the progression of the HF diet-mediated metabolic disorder based on early and late events, and the possible molecular targets of WP and PP extract in preventive and intervention strategies. The body surface area normalization equation gave a conversion equivalent to a daily human intake dose of 2101-3502 mg phenolics that can be obtained from 110-183 g pecan kernels/day (22-38 whole pecans) or 21.6-36 g defatted pecan flour/day for an average person of 60 kg. This work lays the groundwork for future clinical studies.

Keywords: bioactive compounds; dysbiosis; functional food; insulin resistance; mitochondrial activity; obesity; pecans; polyphenols.

MeSH terms

  • Animals
  • Carya*
  • Diabetes Mellitus* / metabolism
  • Diet, High-Fat / adverse effects
  • Dysbiosis / metabolism
  • Dysbiosis / prevention & control
  • Energy Metabolism
  • Fatty Liver* / prevention & control
  • Humans
  • Hypertrophy
  • Inflammation / metabolism
  • Inflammation / prevention & control
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Obesity / etiology
  • Obesity / prevention & control
  • Polyphenols / metabolism
  • Polyphenols / pharmacology

Substances

  • Polyphenols

Grants and funding

We acknowledge funding from the Texas Pecan Board and a grant from the Texas Department of Agriculture. This research was supported in part by funding from the Texas A&M AgriLife Institute for Advancing Health through Agriculture (IHA).The APC was funded by Fundación para la Salud y la Educación Dr. Salvador Zubirán A.C. [NAN-1924-18-19 to CDP] and by Consejo Nacional de Ciencia y Tecnología (CONACyT) [A1-S-41077 to ITV].